Anika receives 510(k) clearance for integrity™ implant system, a regenerative hyaluronic acid-based patch system for augmentation of rotator cuff repairs

Complete integrity implant system is now fully cleared; targeting launch in q1-2024 integrity is highly differentiated by its knitted structure, resulting in higher strength and greater regenerative capacity compared to first generation bovine collagen patches1 integrity marks anika's expansion of its proprietary regenerative portfolio and entrance into the over $150 million2 u.s. rotator cuff augmentation market bedford, mass., aug. 17, 2023 (globe newswire) -- anika therapeutics, inc. (nasdaq: anik), a global joint preservation company focused on early intervention orthopedics, today announced that it has received the final 510(k) clearance from the fda for the integrity™ implant system.
ANIK Ratings Summary
ANIK Quant Ranking